(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RASTRUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RASTRUM

ST13

US500000079346809

Class

5, 9, 35, 42

Filing

79346809

Registration

7178495

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

08/06/2026

Trademark type

Word

Nice classes

5, 9, 35, 42

Filing date

02/07/2022

Registration date

10/03/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/03/2023

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

SWAIN, MICHELE LYNN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Inventia Life Science Pty Ltd

Representatives

Rachelle A. Dubow, Esq. Morgan, Lewis & Bockius LLP

Technical classification

Nice Classes

Class 5Class 9Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Surgical biological tissue grafts; engineered biological living tissues and 3d cell cultures for medical and surgical use; tissue-regenerative medical preparations for generating skin cellstissues and organs; biological tissue cultures for medical purposes

Class 9

Scientific and research apparatus and instruments for use in the fields of life science researchbiomedicine and bioprintinglaboratory robots; downloadable software for monitoring and controlling communication between computers and automated machine systems; downloadable software for operating and controlling 3D printersdownloadable operating software to control laboratory apparatus for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable software for the purpose of the manufacture of products by means of a 3D printerincluding medical products; computer peripherals; laboratory instruments and apparatusnamely cell assembly apparatus for laboratory use for fabrication of 3D engineered living tissues and 3D cell cultures; downloadable electronic publicationsnamely pamphletsbrochuresjournalsbooksmanualsnewsletters and booklets in the field of biomedical research3D printingcell printingcell assemblydrug discovery and disease research; recorded and downloadable medianamely audio and video recordings and downloadable audio and video files containing digital matrices and 3-dimensional cell model templates; parts and fittings for all of the foregoingnamely electronic control panels with digital displays for the control of 3D printersprinter cablesink cartridgesunfilledfor printers

Class 35

Data managementnamely database management; retail and wholesale store services for pharmaceuticalmedicalscientificlaboratory and 3D printing consumables and supplies; administrative processing of purchase orders; computerised procurement servicesprocurement of pharmaceutical and medical supplies for othersnamely ordering and purchasing pharmaceutical and medical supplies for others; computerised data processing; compilation of scientific information into databases; business administration in the nature of maintenance of registers for othersincluding registers relating to device history and maintenance history

Class 42

Industrial analysis and research in the field of bioprinting3D printingdrug discoverybiomedicine and disease research; industrial design; design and development of computer software; software-as-a-service featuring software for use in the field of biomedical researchdrug discovery and disease research to design and control experimentsto identifyselect and print biomaterials for the purpose of experimentsto clean and maintain bioprinters and 3D printers; platform-as-a-service featuring software for use in the field of biomedical researchdrug discovery and disease research to design and control experimentsto identifyselect and print biomaterials for the purpose of experimentsto clean and maintain bioprinters and 3D printers; providing online non-downloadable software featuring software for use in the field of biomedical researchdrug discovery and disease research to design and control experimentsto identifyselect and print biomaterials for the purpose of experimentsto clean and maintain bioprinters and 3D printers.; computer programming; installationrepair and maintenance of computer software; analysis of statistical data for scientific research; design of software; design of biological materials; design services relating to printing and product designincluding design of models and matrices for use in 3-dimensional printing; research relating to design; laboratory research in the field of bioprinting and the creation and engineering of 3D cells and living tissues; biomedical research; cloud computing featuring software for use in the field of biomedical researchdrug discovery and disease research to design and control experimentsto identifyselect and print biomaterials for the purpose of experimentsto clean and maintain bioprinters and 3D printers.; technical advisory services relating to scientific products and scientific research; scientific research into the development of new products; engineering servicesincluding hydrogel engineering3D cell culture engineering and tissue engineering; providing technical support servicesnamely technical advice regarding medical and diagnostic laboratory instruments and systems; providing online non-downloadable web-based software platform for laboratory and diagnostic equipment information managementmonitoring and analysis; providing informationincluding onlineabout all of the foregoing

Publications

History of USPTO decisions and trademark events.

31 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/06/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/30/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/23/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/30/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/08/2024

FIMP

FINAL DISPOSITION PROCESSED

01/08/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/03/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/03/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/18/2023

PUBO

PUBLISHED FOR OPPOSITION

07/18/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/28/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/14/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/05/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/05/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/01/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/01/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/01/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/01/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/01/2023

RFNT

REFUSAL PROCESSED BY IB

01/05/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/10/2022

RFRR

REFUSAL PROCESSED BY MPU

12/10/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/29/2022

CNRT

NON-FINAL ACTION WRITTEN

09/28/2022

DOCK

ASSIGNED TO EXAMINER

09/28/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/05/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/04/2022

Continuous trademark protection

Get notified about every new filing that threatens RASTRUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.